Egypt Oncology Drug Market Size, Share, Price, Trends, Growth, Analysis, Outlook, Report, Forecast 2023-2028

The Egypt Oncology Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Oncology Drug market. This report explores all the key factors affecting the growth of the global Egypt Oncology Drug market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141586/

Egypts Oncology drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In Egypt, noncommunicable diseases are responsible for 85% of deaths, with cancers representing the second most common cause of mortality (14%) after cardiovascular diseases (46%). It has an ambitious plan for preventing and controlling non-communicable diseases, including cancer, which was initiated in 2018 (known as the Egypt National Multisectoral Action Plan for Prevention and Control of Noncommunicable Diseases).

In 2020, there were about 134642 new cancer cases and 89,042 cancer-related deaths in Egypt. Liver and breast cancers are the most common tumors in terms of incidence and mortality.

Patients with cancer in Egypt receive their treatment in General Authority for Health Insurance hospitals, in Ministry of Health and Population or university hospitals at the governments expense, or in the private sector at their own expense or with personal insurance coverage.

Market Drivers

The estimated trends for breast and lung cancer in Egypt are projected to rise in the future. According to World Health Organizations Egypts profile for cancer, the breast cancer cases might go up to 40, 544 by 2040 as compared to the 23,081 cases in 2018. For Lung cancer this figure might go up to 11, 945 cases by 2040 as compared to the 6,045 reported cases in 2018.

Such a rise in the prevalence of cancer among the population is likely to drive the market growth for Oncology Therapeutics in Egypt.

Further, the introduction of the Universal Health Insurance Law by the government in 2018 will see an increase in the number of health institutions and facilities, as the government pledges to take care of non-communicable diseases including cancer which has been a major part of the existing disease burden in Egypt. Such initiatives are forecasted to be a positive growth sign for the oncology therapeutics market in the country.

To Know More About COVID-19 Impact On Egypt Oncology Drug Market @ https://www.prudentmarkets.com/sample-request/141586/

By Disease Indication

The market for the treatment of Oncology disease can be segmented into Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Other Cancers

By Drug Class

By drug class, the market can be segmented into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy

By Route of Administration

Based on route of administration the anti-cancer drug market is segmented into oral, parenteral, and others

By Distribution Channel

By distribution channel, the market for oncology drugs in Egypt can be segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

By End-user

On the basis of end-users, the anti-cancer drug market is segmented into hospitals, home care, specialty clinics, and others

Major Players

Egypt's Oncology diseases drug market boasts of leading global companies such as including Boehringer Ingelheim, AstraZeneca, Novartis, GSK, Sanofi, Pharco, Pfizer, Hikma.

Boehringer Ingelheim, one of the world's leading pharmaceutical companies, signed a three-way agreement with a local Egyptian pharmaceutical company called Egy Drug Company and Poly Pharm in 2019 to effectively regulate commercial ties and ensure access to innovative drugs in Egypt. The agreement also aims at diversifying Boehringer Ingelheim's distributors base locally.

Pfizer operates in Egypt through its 100% owned subsidiary Pfizer Egypt. The company currently has around 70 drugs on the Egyptian market and seeks to introduce six additional innovative products for the treatment of breast cancer, blood thinning, and tumors

AstraZeneca Egypt has launched affordability programs for diabetes and oncology products aiming at increasing patients' access to innovative medicines, decreasing patients' burden, and improving adherence/ compliance to medicines. Due to the increasing importance of oncology, they are planning to launch four products in this treatment area in the next few years, including Lynparza and Imfinzi.

Further, Elekta, a leader in precision radiation medicine, announced that it will establish a permanent office in Cairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141586/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Egypt Oncology Drug Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Egypt Oncology Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Egypt Oncology Drug market
Chapter 2: Exclusive Summary - the basic information of the Egypt Oncology Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Egypt Oncology Drug
Chapter 4: Presenting the Egypt Oncology Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Egypt Oncology Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141586/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Egypt Oncology Drug Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.